financetom
Business
financetom
/
Business
/
Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease
Sep 21, 2025 1:51 AM

09:54 AM EDT, 09/19/2025 (MT Newswires) -- Amgen's ( AMGN ) Uplizna has received a positive opinion from the European Medicines Agency's (EMA) human medicines committee recommending its approval for adults with active immunoglobulin G4-related disease, a rare autoimmune disorder with no authorized treatments in the EU.

The recommendation was based on a phase 3 study of 135 patients that showed Uplizna significantly reduced disease flares compared with placebo, the EMA said Friday.

At 52 weeks, 58.8% of patients on Uplizna achieved corticosteroid-free remission without flares versus 22.4% of those on placebo, according to the statement.

The regulator said safety findings were consistent with its use in neuromyelitis optica spectrum disorders, for which Uplizna is already approved. The most common side effects included infections, joint and back pain, and low lymphocyte counts, it added.

The EMA said the committee's opinion will be forwarded to the European Commission, which will decide on an EU-wide extension of the indication, while national pricing and reimbursement decisions will follow if approval is granted.

Price: 280.05, Change: +4.22, Percent Change: +1.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fortescue iron ore shipments fall short after derailment
Fortescue iron ore shipments fall short after derailment
Apr 23, 2024
April 24 (Reuters) - Australia's Fortescue on Wednesday logged a larger-than-expected decline in third-quarter iron ore shipments, following a derailment of ore cars and weather disruptions that also led to a slight cut in its outlook for annual shipments. The world's fourth-largest iron ore miner said it shipped 43.3 million metric tons of the steel-making commodity in the three months...
FAA probes union claims Boeing retaliated against two engineers in 2022
FAA probes union claims Boeing retaliated against two engineers in 2022
Apr 23, 2024
WASHINGTON (Reuters) -The Federal Aviation Administration said Tuesday it is investigating a union's claims that Boeing retaliated against two employees who in 2022 insisted the planemaker re-evaluate prior engineering work on 777 and 787 jets. The Society of Professional Engineering Employees in Aerospace (SPEEA) said the two unidentified engineers were representatives of the FAA, which delegates some of its oversight...
Tesla could start selling Optimus robots by the end of next year, Musk says
Tesla could start selling Optimus robots by the end of next year, Musk says
Apr 23, 2024
(Reuters) - Tesla's humanoid robot is still in the lab, but it may be ready to sell as soon as the end of next year, chief executive Elon Musk said on Tuesday. Several companies have been betting on humanoid robots to meet potential labor shortages and perform repetitive tasks that could be dangerous or tedious in industries such as logistics,...
Musk's X Corp appeals dismissal of lawsuit against anti-hate group
Musk's X Corp appeals dismissal of lawsuit against anti-hate group
Apr 23, 2024
April 23 (Reuters) - Elon Musk's X appealed the dismissal of its lawsuit against the nonprofit Center for Countering Digital Hate, which faulted him for letting hate speech spread on the social media platform once known as Twitter. X filed a notice of appeal to the 9th U.S. Circuit Court of Appeals on Tuesday. U.S. District Judge Charles Breyer in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved